MEDI-EYE Designated as an Innovative Medical Device for Public Healthcare

 

MEDI-EYE, the flagship medical device of MEDI-IoT, has been officially designated as an Innovative Medical Device for Public Healthcare by the Ministry of Food and Drug Safety (MFDS). This recognition underscores the device’s public health value and groundbreaking technology in the field of eye health treatment.

Recognition for Innovative Technology and Public Value
MEDI-EYE is based on Photo-Bio-Modulation (PBM) technology, designed to treat eye conditions such as dry macular degeneration, diabetic retinopathy, and dry eye syndrome. Its non-invasive treatment approach offers enhanced safety and effectiveness compared to traditional methods.

Significance of the Designation
The Innovative Medical Device designation supports products with advanced technology and public healthcare value, providing benefits such as priority support for clinical research and regulatory approvals. This will enable MEDI-EYE to reach medical professionals and patients more quickly and efficiently.

Company Representative’s Statement
[Company Name] CEO [Representative’s Name] expressed, “We are honored to have MEDI-EYE officially recognized as an Innovative Medical Device for Public Healthcare. This designation validates our technological achievements and motivates us to continue developing state-of-the-art medical devices that advance global healthcare.”

Future Outlook
With plans for global market expansion, MEDI-EYE is currently undergoing key certifications such as KC, FCC, and CE. This recent recognition strengthens its credibility and enhances its competitiveness in the international market.

This achievement is regarded as a significant step toward driving innovation in the medical device industry while prioritizing patient-centered technological development.